Mass spectrometry shows potential for fast SARS-CoV-2 recognition Kumar Jeetendra | August 10, 2020 A team from SPI in Marcoule discovered by mass spectrometry, in just 3 minutes and without specific reagents, signature peptides of the SARS-CoV-2 virus in clinical samples (nasopharyngeal swabs). It hence gives a proof of concept concerning the usage of the technique as a potential option to PCR, now the reference process. Quick but nonetheless …
Robust YMC-Triart C18 columns are the ideal decision for reliable and reproducible (U)HPLC examinations of peptides and oligonucleotides Kumar Jeetendra | October 12, 2020 Robust YMC-Triart C18 columns are the perfect choice for reliable and reproducible (U)HPLC analyses of peptides and oligonucleotides with exceptional resolution. The wide temperature- (up to 90°C) and pH-range (1-12) provide increased flexibility. Full MS compatibility is guaranteed due to virtually no column bleeding. Optionally available metal-free bioinert hardware inhibits unwanted interactions and ensures highly …
Inflammation may add to the determination of C. diff disease, shows study Kumar Jeetendra | January 19, 2021 A new study from North Carolina State University indicates that the inflammation brought on by Clostridioides difficile (C. diff) infection gives the pathogen a two-fold advantage: by both creating an inhospitable environment for competing bacteria and supplying nutrients that enable C. diff to thrive. C. diff is a bacterium that causes diarrhea, often with severe …
New device empowers study of SARS-CoV-2 mutant range by ultrasequencing Kumar Jeetendra | February 15, 2021 SARS-CoV-2 genome is three times larger than flu genome. Both consist of NRA molecules which mutate when replicate. It is essential to know its mutant spectrum, in other words, its”fingerprints”, to achieve an appropriate treatment that reduces its infectivity -the capacity of pathogens to invade organisms and cause infections-, since its composition of variables could …
Bacteria residing within inside tumor cells can support malignant growth immunotherapy Kumar Jeetendra | March 22, 2021 Cancer immunotherapy may get a boost from an unexpected direction: bacteria residing within tumor cells. The study may also help clarify the connection between immunotherapy and the intestine microbiome, describing the findings of earlier research that the microbiome impacts the success of immunotherapy. Immunotherapy remedies of the last decade or so have dramatically improved healing …
Researchers develop another approach to grow little pancreas replicas Kumar Jeetendra | September 14, 2021 In collaboration with Cancer Research UK Manchester Institute scientists, engineers from MIT have created a new method to create tiny replicas of pancreas using healthy and cancerous pancreatic cell lines. These models could be used by researchers to test and develop potential treatments for pancreatic cancer. This is one of the most difficult types. Researchers …
Dietary components hold guarantee for working on the health and wellbeing of grown-ups Kumar Jeetendra | January 26, 2022 Research suggests that nutritional supplements that target specific mechanisms that are associated with age-associated cellular decay (AACD), have the potential to improve health and well-being for adults. “Cellular Nutrition and Its Influence on Age-Associated Cellular Decline,” the latest issue of The Gerontological Society of America’s What’s Hot newsletter with accompanying infographic, provides an overview of …
Revolutionizing Medicine: Shape changing RoboCap to deliver drug to cancer cells Kumar Jeetendra | June 14, 2023 Cancer is one of the most devastating medical conditions where unconditional growth of cells takes place and spread to other part of the body, which further leads to various types of cancer including skin cancer, breast cancer, colorectal cancer, pancreatic cancer, prostate cancer and so on. Most prominent approaches to cancer involve chemotherapy and radiation …
